Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Tatva Chintan Pharma Chem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	38,480	24,618	15,840	25,231	36,995	51,166
Market Cap Growth	16.91%	55.42%	-37.22%	-31.80%	-27.70%	-
Enterprise Value	40,028	25,276	15,844	24,403	37,505	50,113
Last Close Price	1890.10	1051.13	675.66	1074.02	1659.94	2293.97

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	61.15	58.54	277.26	83.12	81.33	53.37
Forward PE	51.04	40.11	41.06	29.94	36.07	42.29
PS Ratio	6.80	4.87	4.14	6.41	8.73	11.80
PB Ratio	5.43	3.15	2.14	3.42	7.19	10.82
P/TBV Ratio	5.47	3.16	2.15	3.44	7.19	10.82
P/OCF Ratio	306.36	78.18	63.94	25.73	133.16	252.92
PEG Ratio	0.41	0.32	1.65	0.79	1.13	1.13

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	7.04	5.00	4.14	6.20	8.85	11.56
EV/EBITDA Ratio	35.73	26.79	47.71	35.40	55.46	46.26
EV/EBIT Ratio	51.30	42.76	237.11	55.74	64.15	49.87

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.21	0.15	0.05	0.02	0.33	0.25
Debt / EBITDA Ratio	1.33	1.27	1.09	0.21	2.51	1.10
Net Debt / Equity Ratio	0.19	0.15	0.03	-0.04	0.25	0.12
Net Debt / EBITDA Ratio	1.21	1.21	0.74	-0.45	1.91	0.52
Net Debt / FCF Ratio	-2.09	-1.39	-0.48	1.03	-0.74	-0.81
Asset Turnover	0.64	0.55	0.46	0.50	0.60	0.89
Inventory Turnover	1.54	1.43	1.44	1.16	1.40	1.67
Quick Ratio	0.66	0.60	1.07	1.48	0.54	0.73
Current Ratio	1.59	1.64	2.76	3.74	1.31	2.55
Return on Equity (ROE)	8.02%	5.53%	0.77%	4.85%	9.21%	30.00%
Return on Assets (ROA)	5.50%	4.01%	0.51%	3.47%	5.16%	12.91%
Return on Invested Capital (ROIC)	7.13%	5.23%	0.69%	4.52%	9.97%	23.72%
Return on Capital Employed (ROCE)	10.80%	7.50%	0.90%	5.90%	11.20%	20.60%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.64%	1.71%	0.36%	1.20%	1.23%	1.87%
FCF Yield	-1.68%	-3.34%	-3.25%	-1.21%	-4.74%	-1.35%
Dividend Yield	0.12%	0.19%	0.15%	0.18%	0.12%	0.09%
Payout Ratio	11.15%	5.56%	81.88%	15.41%	9.75%	-
Buyback Yield / Dilution	-0.04%	-	-2.20%	-3.27%	-3.10%	-7.03%
Total Shareholder Return	0.07%	0.19%	-2.05%	-3.08%	-2.98%	-6.94%

Data Source: S&P Global Market Intelligence Last updated: Oct 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error